Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
McKesson
Moodys
Boehringer Ingelheim
McKinsey

Last Updated: November 29, 2022

CLINICAL TRIALS PROFILE FOR IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Ibuprofen; Pseudoephedrine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00240812 ↗ A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting Completed Johnson & Johnson Consumer and Personal Products Worldwide Phase 2 1969-12-31 The purpose of the study is to determine if ibuprofen in combination with pseudoephedrine HCl in the treatment of nightime bedwetting in children is more effective than each drug alone and if the individual drugs are more effective than placebo.
NCT01131780 ↗ Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions Completed Dr. Reddy's Laboratories Limited Phase 1 2004-10-01 The purpose of this study is to assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg under fasting conditions.
NCT01132222 ↗ Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions Completed Dr. Reddy's Laboratories Limited Phase 1 2004-09-01 The purpose of this study is to assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg under fed conditions.
NCT01170637 ↗ Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteer Completed Boehringer Ingelheim Phase 1 2010-07-01 The objective of the current study is to demonstrate bioequivalence of a fixed dose combination tablet containing ibuprofen 200 mg and pseudoephedrine-HCl 30 mg (Test) and RhinAdvilĀ® (Reference) a fixed dose combination tablet containing ibuprofen 200 mg and pseudoephedrine-HCl 30 mg following orally administration.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ibuprofen; Pseudoephedrine Hydrochloride

Condition Name

Condition Name for Ibuprofen; Pseudoephedrine Hydrochloride
Intervention Trials
Healthy 3
Enuresis 1
Fever 1
Healthy Volunteers 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ibuprofen; Pseudoephedrine Hydrochloride
Intervention Trials
Malnutrition 1
Urinary Incontinence 1
Nocturnal Enuresis 1
Enuresis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ibuprofen; Pseudoephedrine Hydrochloride

Trials by Country

Trials by Country for Ibuprofen; Pseudoephedrine Hydrochloride
Location Trials
India 2
Germany 1
Canada 1
South Africa 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ibuprofen; Pseudoephedrine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Ibuprofen; Pseudoephedrine Hydrochloride
Clinical Trial Phase Trials
Phase 2 1
Phase 1 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ibuprofen; Pseudoephedrine Hydrochloride
Clinical Trial Phase Trials
Completed 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ibuprofen; Pseudoephedrine Hydrochloride

Sponsor Name

Sponsor Name for Ibuprofen; Pseudoephedrine Hydrochloride
Sponsor Trials
Dr. Reddy's Laboratories Limited 2
Boehringer Ingelheim 2
Johnson & Johnson Consumer and Personal Products Worldwide 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ibuprofen; Pseudoephedrine Hydrochloride
Sponsor Trials
Industry 6
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Merck
Mallinckrodt
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.